HAL (France)open access
Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study
1, IL-7 pathway, Primary Sjögren's syndrome, Sjogren's syndrome, Prevalence, Imaging mass cytometry, Autoimmune diseases, Anti-IL-7R therapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 288098
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.